drugset / Trial / NCT01111981
Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to ascertain the safety and efficacy of Clobetasol Propionate 0.05% E Foam in the treatment of Central Centrifugal Cicatricial Alopecia.
Timeline
- Start
- 2009-10
- Primary completion
- 2010-02
- Completion
- 2010-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | clobetasol propionate | Small molecule | 0.05 % | Topical |